TEVA - Teva Pharmaceutical Industries Limited

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-22,385,00021,903,00019,652,000
Cost of Revenue-11,493,0009,661,0008,296,000
Gross Profit-10,892,00012,242,00011,356,000
Operating Expenses
Research Development-1,848,0002,111,0001,525,000
Selling General and Administrative-4,986,0005,145,0004,838,000
Non Recurring----
Others-80,00065,000-40,000
Total Operating Expenses-18,407,00016,982,00014,619,000
Operating Income or Loss-3,978,0004,921,0005,033,000
Income from Continuing Operations
Total Other Income/Expenses Net--22,360,000-4,089,000-2,802,000
Earnings Before Interest and Taxes-3,978,0004,921,0005,033,000
Interest Expense--875,000-546,000-270,000
Income Before Tax--18,382,000832,0002,231,000
Income Tax Expense--1,933,000521,000634,000
Minority Interest-1,386,0001,656,000158,000
Net Income From Continuing Ops--16,449,000311,0001,597,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--16,265,000329,0001,588,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--16,525,00068,0001,573,000